Healthcare Supplier Cencora Seen as Strong Buy with Upside

Analyst cites solid fundamentals, dividend growth, and low payout ratio for NYSE-listed Cencora.

Apr. 12, 2026 at 6:08am

Got story updates? Submit your updates here. ›

An extreme close-up of complex medical equipment and supply chain machinery, conveying the industrial scale and precision of Cencora's operations as a major healthcare supplier.Cencora's robust healthcare supply chain and manufacturing capabilities underpin its position as a leading provider in the industry.Austin Today

Cencora (NYSE:COR), a major healthcare supply company, has been reaffirmed as a strong buy recommendation by analyst Albert Anthony. The author cites the firm's solid fundamentals, consistent dividend growth, low payout ratio, and A-level credit rating as key factors driving potential upside for the stock.

Why it matters

As the healthcare industry continues to evolve, reliable suppliers like Cencora play a critical role in supporting hospitals, clinics, and other providers. Investors are closely watching Cencora's performance as an indicator of broader trends in the sector.

The details

In his analysis, Anthony highlights Cencora's diversified product portfolio, efficient distribution network, and long-standing customer relationships as competitive advantages. The company has also demonstrated a commitment to shareholder returns through steady dividend increases, while maintaining a conservative payout ratio.

  • Cencora has been publicly traded on the NYSE since 2015.

The players

Cencora

A major healthcare supply company that provides a wide range of medical products and equipment to hospitals, clinics, and other healthcare providers.

Albert Anthony

A business author, analyst, and contributor for the investing platform Seeking Alpha, with expertise in sectors such as finance, REITs, and healthcare.

Got photos? Submit your photos here. ›

What they’re saying

“Cencora's strong fundamentals, consistent dividend growth, and low payout ratio make it a compelling investment opportunity in the healthcare supply space.”

— Albert Anthony, Analyst and Contributor, Seeking Alpha

What’s next

Investors will be closely watching Cencora's upcoming quarterly earnings report and any further commentary from the company on its growth strategies and market positioning.

The takeaway

Cencora's resilience and adaptability in the evolving healthcare landscape have made it a stock to watch for investors seeking exposure to a well-established supplier with solid fundamentals and potential for continued upside.